Corium Announces Issuance of Key U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease
June 13, 2018 07:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at the Jefferies 2018 Global Healthcare Conference
May 24, 2018 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights
May 14, 2018 16:01 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018
May 08, 2018 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018...
Corium to Present at the 17th Annual Needham Healthcare Conference
March 19, 2018 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
March 01, 2018 08:35 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
February 28, 2018 16:15 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
February 08, 2018 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at Upcoming Healthcare Investor Conferences
February 06, 2018 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018
February 01, 2018 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first quarter ended December 31, 2017...